Advertisement
Screener

Citadel Advisors LLC Historic Quarter Change: USA Bonds: Other Debt, Added, 2017 Q2

CITADEL ADVISORS LLC historic quarter change: USA Bonds: Other Debt, Added

In other debt filed by principal amount (debentures, bonds) (listed in the US), over 51 quarters from 2013-06-30 to 2026-03-31, CITADEL ADVISORS LLC opened 884 positions, added to 1,270, reduced 1,104 and sold out of 996.

  • Q2 2017: Stock MOLINA HEALTHCARE INC; Country of operation —; Class Bond; Principal before $27,000,000.
  • Q2 2017: Stock MICRON TECHNOLOGY INC; Country of operation —; Class Bond; Principal before $66,370,000.
  • Q2 2017: Stock HEALTHWAYS INC; Country of operation —; Class Bond; Principal before $50,440,000.
  • Q2 2017: Stock PROOFPOINT INC; Country of operation —; Class Bond; Principal before $98,685,000.

Each consecutive pair of Form 13F-HR filings compared (SEC CIK 1423053), 51 quarters: Q1 2026 (2025-12-31 to 2026-03-31, filed 2026-05-15); Q4 2025 (2025-09-30 to 2025-12-31, filed 2026-02-17); Q3 2025 (2025-06-30 to 2025-09-30, filed 2025-11-14); Q2 2025 (2025-03-31 to 2025-06-30, filed 2025-08-14); Q1 2025 (2024-12-31 to 2025-03-31, filed 2025-05-15); Q4 2024 (2024-09-30 to 2024-12-31, filed 2025-02-14); Q3 2024 (2024-06-30 to 2024-09-30, filed 2024-11-14); Q2 2024 (2024-03-31 to 2024-06-30, filed 2024-08-14); Q1 2024 (2023-12-31 to 2024-03-31, filed 2024-05-15); Q4 2023 (2023-09-30 to 2023-12-31, filed 2024-02-14); Q3 2023 (2023-06-30 to 2023-09-30, filed 2023-11-14); Q2 2023 (2023-03-31 to 2023-06-30, filed 2023-08-14); Q1 2023 (2022-12-31 to 2023-03-31, filed 2023-05-15); Q4 2022 (2022-09-30 to 2022-12-31, filed 2023-02-14); Q3 2022 (2022-06-30 to 2022-09-30, filed 2022-11-14); Q2 2022 (2022-03-31 to 2022-06-30, filed 2022-08-15); Q1 2022 (2021-12-31 to 2022-03-31, filed 2022-05-16); Q4 2021 (2021-09-30 to 2021-12-31, filed 2022-02-14); Q3 2021 (2021-06-30 to 2021-09-30, filed 2021-11-15); Q2 2021 (2021-03-31 to 2021-06-30, filed 2021-08-16); Q1 2021 (2020-12-31 to 2021-03-31, filed 2021-05-17); Q4 2020 (2020-09-30 to 2020-12-31, filed 2021-02-16); Q3 2020 (2020-06-30 to 2020-09-30, filed 2020-11-16); Q2 2020 (2020-03-31 to 2020-06-30, filed 2020-08-14); Q1 2020 (2019-12-31 to 2020-03-31, filed 2020-05-15); Q4 2019 (2019-09-30 to 2019-12-31, filed 2020-02-14); Q3 2019 (2019-06-30 to 2019-09-30, filed 2019-11-14); Q2 2019 (2019-03-31 to 2019-06-30, filed 2019-08-14); Q1 2019 (2018-12-31 to 2019-03-31, filed 2019-05-15); Q4 2018 (2018-09-30 to 2018-12-31, filed 2019-02-14); Q3 2018 (2018-06-30 to 2018-09-30, filed 2018-11-13); Q2 2018 (2018-03-31 to 2018-06-30, filed 2018-08-10); Q1 2018 (2017-12-31 to 2018-03-31, filed 2018-05-11); Q4 2017 (2017-09-30 to 2017-12-31, filed 2018-02-09); Q3 2017 (2017-06-30 to 2017-09-30, filed 2017-11-09); Q2 2017 (2017-03-31 to 2017-06-30, filed 2017-08-11); Q1 2017 (2016-12-31 to 2017-03-31, filed 2017-05-12); Q4 2016 (2016-09-30 to 2016-12-31, filed 2017-02-10); Q3 2016 (2016-06-30 to 2016-09-30, filed 2016-11-10); Q2 2016 (2016-03-31 to 2016-06-30, filed 2016-08-12); Q1 2016 (2015-12-31 to 2016-03-31, filed 2016-05-13); Q4 2015 (2015-09-30 to 2015-12-31, filed 2016-02-12); Q3 2015 (2015-06-30 to 2015-09-30, filed 2015-11-16); Q2 2015 (2015-03-31 to 2015-06-30, filed 2015-08-14); Q1 2015 (2014-12-31 to 2015-03-31, filed 2015-05-15); Q4 2014 (2014-09-30 to 2014-12-31, filed 2015-02-18); Q3 2014 (2014-06-30 to 2014-09-30, filed 2014-11-14); Q2 2014 (2014-03-31 to 2014-06-30, filed 2014-08-14); Q1 2014 (2013-12-31 to 2014-03-31, filed 2014-05-15); Q4 2013 (2013-09-30 to 2013-12-31, filed 2014-02-14); Q3 2013 (2013-06-30 to 2013-09-30, filed 2013-11-14). Rows for the same security, class and put/call are added together. Value change is the filed value at each quarter end, so it includes the price move. Only the filings held here are compared; the firm's 13F-HR filings go back to the quarter ended 2009-12-31.

QuarterStockCountry of operationClassPrincipal beforePrincipal afterShare changeValue beforeValue afterValue changeFiled
Q2 2017MOLINA HEALTHCARE INC
CUSIP 60855RAC4
—Bond$27,000,000$54,000,000+27,000,000$34,508$94,500+$59,9922017-08-11
Q2 2017MICRON TECHNOLOGY INC
CUSIP 595112AV5
—Bond$66,370,000$85,306,000+18,936,000$177,469$234,690+$57,2212017-08-11
Q2 2017HEALTHWAYS INC
CUSIP 422245AB6
—Bond$50,440,000$62,890,000+12,450,000$77,796$129,182+$51,3862017-08-11
Q2 2017PROOFPOINT INC
CUSIP 743424AB9
—Bond$98,685,000$107,776,000+9,091,000$188,887$239,625+$50,7382017-08-11
Q2 2017PRICELINE GRP INC
CUSIP 741503AQ9
—Bond$81,030,000$94,530,000+13,500,000$152,601$186,573+$33,9722017-08-11
Q2 2017TTM TECHNOLOGIES INC
CUSIP 87305RAD1
—Bond$12,992,000$28,517,000+15,525,000$22,958$53,598+$30,6402017-08-11
Q2 2017SALESFORCE COM INC
CUSIP 79466LAD6
—Bond$10,000,000$30,178,000+20,178,000$12,888$39,981+$27,0932017-08-11
Q2 2017MERCADOLIBRE INC
CUSIP 58733RAB8
—Bond$30,178,000$38,575,000+8,397,000$52,509$78,190+$25,6812017-08-11
Q2 2017NEVRO CORP
CUSIP 64157FAA1
—Bond$11,200,000$33,400,000+22,200,000$13,595$35,855+$22,2602017-08-11
Q2 2017MICROCHIP TECHNOLOGY INC
CUSIP 595017AD6
—Bond$140,000,000$147,000,000+7,000,000$201,006$220,322+$19,3162017-08-11
Q2 2017LIBERTY INTERACTIVE LLC
CUSIP 530610AD6
—Bond$38,063,000$51,781,000+13,718,000$42,860$59,333+$16,4732017-08-11
Q2 2017SILVER STD RES INC
CUSIP 82823LAC0
—Bond$28,031,000$45,031,000+17,000,000$27,525$43,835+$16,3102017-08-11
Q2 2017WORKDAY INC
CUSIP 98138HAC5
—Bond$16,500,000$27,500,000+11,000,000$18,871$33,953+$15,0822017-08-11
Q2 2017BLACKSTONE MTG TR INC
CUSIP 09257WAA8
—Bond$20,082,000$32,514,000+12,432,000$23,003$37,728+$14,7252017-08-11
Q2 2017ALBANY MOLECULAR RESH INC
CUSIP 012423AB5
—Bond$41,725,000$42,225,000+500,000$45,686$60,318+$14,6322017-08-11
Q2 2017CTRIP COM INTL LTD
CUSIP 22943FAD2
—Bond$56,659,000$62,659,000+6,000,000$74,380$88,621+$14,2412017-08-11
Q2 2017ISIS PHARMACEUTICALS INC DEL
CUSIP 464337AJ3
—Bond$9,957,000$21,500,000+11,543,000$9,603$22,817+$13,2142017-08-11
Q2 2017ENCORE CAP GROUP INC
CUSIP 292554AF9
—Bond$2,500,000$13,873,000+11,373,000$2,370$14,865+$12,4952017-08-11
Q2 2017CTRIP COM INTL LTD
CUSIP 22943FAF7
—Bond$7,500,000$16,750,000+9,250,000$8,313$19,334+$11,0212017-08-11
Q2 2017RENEWABLE ENERGY GROUP INC
CUSIP 75972AAA1
—Bond$4,173,000$13,373,000+9,200,000$4,211$14,877+$10,6662017-08-11
Q2 2017PDC ENERGY INC
CUSIP 69327RAD3
—Bond$20,750,000$35,000,000+14,250,000$21,295$31,822+$10,5272017-08-11
Q2 2017WRIGHT MED GROUP INC
CUSIP 98235TAE7
—Bond$22,500,000$33,500,000+11,000,000$26,888$37,343+$10,4552017-08-11
Q2 2017IRONWOOD PHARMACEUTICALS INC
CUSIP 46333XAD0
—Bond$44,150,000$48,150,000+4,000,000$55,141$64,554+$9,4132017-08-11
Q2 2017NUVASIVE INC
CUSIP 670704AG0
—Bond$71,500,000$77,363,000+5,863,000$97,718$107,049+$9,3312017-08-11
Q2 2017ACORDA THERAPEUTICS INC
CUSIP 00484MAA4
—Bond$6,257,000$16,257,000+10,000,000$5,328$13,962+$8,6342017-08-11
Q2 2017MICRON TECHNOLOGY INC
CUSIP 595112AU7
—Bond$17,938,000$20,438,000+2,500,000$47,368$55,700+$8,3322017-08-11
Q2 2017LIBERTY MEDIA CORP DELAWARE
CUSIP 531229AB8
—Bond$72,500,000$76,100,000+3,600,000$82,257$90,370+$8,1132017-08-11
Q2 2017CARRIAGE SVCS INC
CUSIP 143905AM9
—Bond$17,403,000$23,136,000+5,733,000$22,683$30,120+$7,4372017-08-11
Q2 201751JOB INC
CUSIP 316827AC8
—Bond$20,609,000$25,109,000+4,500,000$22,065$29,350+$7,2852017-08-11
Q2 2017FLUIDIGM CORP DEL
CUSIP 34385PAA6
—Bond$9,892,000$21,758,000+11,866,000$6,738$13,706+$6,9682017-08-11
Q2 2017INTERCEPT PHARMACEUTICALS IN
CUSIP 45845PAA6
—Bond$43,100,000$48,100,000+5,000,000$40,244$46,963+$6,7192017-08-11
Q2 2017APOLLO COML REAL EST FIN INC
CUSIP 03762UAA3
—Bond$15,000,000$20,500,000+5,500,000$16,491$22,519+$6,0282017-08-11
Q2 2017ROYAL GOLD INC
CUSIP 780287AA6
—Bond$4,673,000$10,000,000+5,327,000$4,930$10,796+$5,8662017-08-11
Q2 2017RYLAND GROUP INC
CUSIP 783764AQ6
—Bond$3,000,000$8,000,000+5,000,000$3,774$9,486+$5,7122017-08-11
Q2 2017IGI LABORATORIES INC
CUSIP 449575AB5
—Bond$21,345,000$24,845,000+3,500,000$21,451$26,646+$5,1952017-08-11
Q2 2017FIREEYE INC
CUSIP 31816QAD3
—Bond$48,908,000$52,908,000+4,000,000$43,952$48,258+$4,3062017-08-11
Q2 2017THERAVANCE BIOPHARMA INC
CUSIP 88339KAA0
—Bond$16,750,000$18,750,000+2,000,000$21,257$25,363+$4,1062017-08-11
Q2 2017VEECO INSTRS INC DEL
CUSIP 922417AD2
—Bond$53,000,000$58,000,000+5,000,000$55,228$59,331+$4,1032017-08-11
Q2 2017ARRAY BIOPHARMA INC
CUSIP 04269XAA3
—Bond$18,306,000$22,070,000+3,764,000$25,982$29,896+$3,9142017-08-11
Q2 2017BROADSOFT INC
CUSIP 11133BAD4
—Bond$21,545,000$23,545,000+2,000,000$25,805$29,446+$3,6412017-08-11
Q2 2017PDL BIOPHARMA INC
CUSIP 69329YAG9
—Bond$8,000,000$11,600,000+3,600,000$7,038$10,467+$3,4292017-08-11
Q2 2017WABASH NATL CORP
CUSIP 929566AH0
—Bond$6,508,000$7,807,000+1,299,000$11,821$14,960+$3,1392017-08-11
Q2 2017GSV CAP CORP
CUSIP 36191JAB7
—Bond$7,000,000$10,000,000+3,000,000$6,900$9,858+$2,9582017-08-11
Q2 2017SOLARCITY CORP
CUSIP 83416TAC4
—Bond$4,000,000$6,000,000+2,000,000$3,581$5,683+$2,1022017-08-11
Q2 2017ENCORE CAP GROUP INC
CUSIP 292554AD4
—Bond$3,500,000$4,500,000+1,000,000$3,858$5,814+$1,9562017-08-11
Q2 2017SPECTRUM PHARMACEUTICALS INC
CUSIP 84763AAB4
—Bond$10,000,000$11,450,000+1,450,000$10,138$12,031+$1,8932017-08-11
Q2 2017OLD REP INTL CORP
CUSIP 680223AH7
—Bond$10,000,000$12,000,000+2,000,000$13,344$15,229+$1,8852017-08-11
Q2 2017JANUS HENDERSON GROUP PLC
CUSIP 47102XAH8
—Bond$868,000$1,868,000+1,000,000$1,137$2,747+$1,6102017-08-11
Q2 2017B2GOLD CORP
CUSIP 11777QAB6
—Bond$14,000,000$15,500,000+1,500,000$14,923$16,253+$1,3302017-08-11
Q2 2017GAIN CAP HLDGS INC
CUSIP 36268WAB6
—Bond$19,500,000$21,500,000+2,000,000$19,405$20,726+$1,3212017-08-11
Q2 2017NEW MTN FIN CORP
CUSIP 647551AB6
—Bond$27,165,000$28,165,000+1,000,000$28,127$29,316+$1,1892017-08-11
Q2 2017ARBOR RLTY TR INC
CUSIP 038923AA6
—Bond$6,000,000$6,750,000+750,000$6,301$7,209+$9082017-08-11
Q2 2017SUCAMPO PHARMACEUTICALS INC
CUSIP 864909AA4
—Bond$11,500,000$12,000,000+500,000$11,395$11,741+$3462017-08-11